G&G Biotechnology

What G&G Biotechnology does

G&G Biotechnology is an Israeli medical device company founded in 2005 and based in Haifa, developing a complete product line of lightweight breast implants for augmentation and reconstruction. Its core innovation, B-Lite® lightweight implant technology, is described as the first true innovation in breast implant technology in over 30 years, using a proprietary combination of clinically proven materials to reduce implant weight by up to 30% without reducing volume or size (a 350cc B-Lite® implant weighs approximately 270g versus ~350g for a traditional silicone implant). The technology is intended to reduce long-term stress and strain on breast soft tissues. The company operates under founder and CEO Dael Govreen-Segal.

G&G's commercial reach is achieved primarily through its manufacturing and distribution partnership with POLYTECH Health & Aesthetics GmbH, a German manufacturer with over 35 years of industry experience, millions of implants produced, and a global footprint in over 90 countries. The combined product portfolio spans over 2,000 breast and body-contouring implant options (round and anatomical/teardrop shapes, multiple profiles, gluteal and body-contouring extensions), supported by the IMPLANTS OF EXCELLENCE warranty programme for both breast and gluteal implants. End markets served are patients seeking breast augmentation or reconstruction (post-mastectomy, trauma, or congenital conditions) and the plastic and reconstructive surgeons who perform these procedures.

The business model is a medical device hardware sales / technology licensing arrangement: implants are manufactured and sold through POLYTECH's surgeon-directed B2B sales model to surgeons and hospitals, with patients directed to the company's surgeon locator tool. Pricing is not publicly disclosed and is determined by procedure type, implant specifications, and volume through surgeon/clinic procurement channels. No revenue figures, headcount data, funding history, or independent sales infrastructure for G&G were disclosed in the available source material.

Name

G&G Biotechnology

Legal name

POLYTECH Health & Aesthetics GmbH

Website

https://gg-bio.com

Company type

Private

Founded year

1989

Operating status

Operating

Short description

G&G Biotechnology is an Israeli medical device company developing B-Lite® lightweight breast implant technology for augmentation and reconstruction, commercialized globally through its manufacturing and distribution partnership with POLYTECH Health & Aesthetics across 90+ countries.

Ownership category

akta.pro rank

Product category

Breast Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Elastomers & Synthetic Rubber Polymer Manufacturing (SBR, BR, NBR, EPDM, Silicone base polymers) (IMANAAAD)

Keywords

• Lightweight breast implants
• Breast augmentation devices
• Breast reconstruction implants
• Medical device development
• Cosmetic surgery implants

Headquarters

HQ city

Haifa

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales

Revenue model

1. Breast Implant Sales: POLYTECH designs, develops, and manufactures silicone breast implants and body-contouring implants sold to surgeons and hospitals for use in breast augmentation and reconstruction procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

G&G Biotechnology develops a complete product line of lightweight breast implants for breast augmentation and reconstruction. The company is the originator of the B-Lite® lightweight breast implant technology, which uses a unique combination of clinically proven materials to reduce implant weight by up to 30% without reducing volume or size, reducing stress and strain on breast soft tissues over time.

Product overview

POLYTECH Health & Aesthetics is a German manufacturer of silicone breast implants and body-contouring implants with over 35 years of experience. The company offers a comprehensive portfolio of over 2,000 breast and body-contouring implant options, including standard breast implants (available in round and anatomical/teardrop shapes), B-Lite® lightweight implants (up to 30% lighter than conventional implants), and gluteal implants. The company also provides the IMPLANTS OF EXCELLENCE warranty programme for patients, covering replacement implants in specific cases. POLYTECH serves global markets in over 90 countries and is the only German manufacturer of breast implants.

Differentiator

Problem solved

Functional benefit

Brands

• B-Lite®: B-Lite® is the first true innovation in breast implant technology in over 30 years. A unique combination of clinically proven materials that reduce the weight of a breast implant without reducing its volume or size. Up to 30% lighter than conventional implants, B-Lite® implants reduce stress and strain on the breast soft tissues over time.

Products and services

• B-Lite® Lightweight Breast Implants

Quantifiable outcome

• Up to 30% lighter than conventional implants — a 350cc lightweight implant weighs approximately 270g versus ~350g for traditional silicone

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• POLYTECH Health & Aesthetics: Manufacturer and global distributor of B-Lite® implants in 90+ countries. Functions as G&G's primary commercialization and manufacturing partner, directly tied to G&G's commercial trajectory and the most comparable entity in the dataset.
• Establishment Labs: Public medical device company (NASDAQ: ESTA) focused on breast aesthetics and reconstruction, marketing the Motiva implant line. A direct breast implant competitor whose product range and surgeon-direct GTM model closely mirrors the industry G&G serves through POLYTECH.
• Sientra: US-based aesthetics company (acquired by Tiger Aesthetics in 2024) specializing in breast implants for augmentation and reconstruction. A direct competitor with overlapping surgeon customer base and similar product portfolio.
• GC Aesthetics: Ireland-based manufacturer of silicone breast implants (Perthese, Round and other lines) selling internationally. A direct competitor focused exclusively on breast aesthetics in markets that overlap with POLYTECH's European footprint.
• Sebbin: French silicone breast and body-contouring implant manufacturer serving European and international markets. A direct niche competitor with a similar premium, surgeon-directed positioning to POLYTECH.

Broad incumbents

• Allergan Aesthetics (AbbVie): Owner of the Natrelle breast implant line and the largest aesthetics franchise globally via AbbVie. A broad incumbent whose breast aesthetics business competes with B-Lite®/POLYTECH across most major markets.
• Mentor (Johnson & Johnson): Johnson & Johnson subsidiary manufacturing MemoryGel and other silicone breast implants with a long-established global footprint. Broad incumbent in the same product category as G&G's B-Lite® platform.

Emerging players

• Ideal Implant: US-based developer of a structured saline-filled breast implant, representing an alternative technology approach within the same breast implant category. Comparable as an innovation-driven breast implant specialist competing for surgeon mindshare.

Regional players

• HansBiomed: Korean manufacturer of silicone breast implants (Bellagel, HansImplant) primarily serving Asian markets. A regional player whose product mix and surgeon-direct model are similar to G&G's category but whose geographic focus largely does not overlap with POLYTECH's European-centric footprint.
• Silimed: Brazilian manufacturer of silicone breast and body-contouring implants with strong Latin American and some European market presence. A regional competitor in the same surgical implant category with comparable surgeon-direct distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/polytechhealth
• YouTubeyoutube.com/user/polytechhealth
• Facebookfacebook.com/PolytechHealth.en
• LinkedInlinkedin.com/company/polytech-health-&-aesthetics
• Instagraminstagram.com/polytechhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about G&G Biotechnology